Your browser is no longer supported. Please, upgrade your browser.
PRAH PRA Health Sciences, Inc. daily Stock Chart
PRAH [NASD]
PRA Health Sciences, Inc.
Index- P/E27.61 EPS (ttm)3.59 Insider Own0.20% Shs Outstand65.84M Perf Week-10.82%
Market Cap6.53B Forward P/E15.11 EPS next Y6.57 Insider Trans-99.04% Shs Float63.13M Perf Month-6.17%
Income239.10M PEG2.30 EPS next Q1.19 Inst Own- Short Float3.78% Perf Quarter-7.21%
Sales3.00B P/S2.18 EPS this Y55.40% Inst Trans1.39% Short Ratio4.83 Perf Half Y1.50%
Book/sh14.62 P/B6.78 EPS next Y12.59% ROA4.70% Target Price120.69 Perf Year-13.09%
Cash/sh2.76 P/C35.92 EPS next 5Y12.02% ROE14.80% 52W Range85.00 - 115.50 Perf YTD-10.76%
Dividend- P/FCF38.97 EPS past 5Y28.70% ROI10.20% 52W High-16.42% Beta1.13
Dividend %- Quick Ratio1.10 Sales past 5Y23.70% Gross Margin28.90% 52W Low13.56% ATR2.86
Employees16400 Current Ratio1.10 Sales Q/Q8.80% Oper. Margin10.10% RSI (14)26.21 Volatility3.74% 2.34%
OptionableYes Debt/Eq0.00 EPS Q/Q4.70% Profit Margin5.30% Rel Volume0.87 Prev Close99.19
ShortableYes LT Debt/Eq1.47 EarningsFeb 20 AMC Payout0.00% Avg Volume494.14K Price96.53
Recom2.00 SMA20-9.51% SMA50-9.74% SMA200-3.95% Volume282,673 Change-2.68%
Jan-10-20Downgrade Goldman Buy → Neutral $130 → $120
Jan-07-20Initiated Citigroup Neutral $120
Nov-14-19Upgrade Wolfe Research Peer Perform → Outperform
Sep-19-19Initiated Goldman Buy $126
Sep-13-19Upgrade KeyBanc Capital Markets Sector Weight → Overweight
May-03-19Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Oct-09-18Initiated UBS Neutral
Oct-04-18Initiated Evercore ISI In-line
Jan-24-18Downgrade Mizuho Buy → Neutral $86
Dec-11-17Initiated Barclays Overweight $94
Dec-01-17Reiterated Mizuho Buy $82 → $87
Aug-17-17Initiated Raymond James Outperform $89
Jun-26-17Initiated BofA/Merrill Buy $89
Feb-27-17Upgrade Avondale Mkt Underperform → Mkt Perform
Feb-06-17Upgrade Credit Suisse Neutral → Outperform
Sep-06-16Downgrade UBS Buy → Neutral $50 → $55
Jun-21-16Initiated First Analysis Sec Equal-Weight $47
Jun-21-16Initiated Credit Suisse Neutral $43
Jun-13-16Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
May-04-16Upgrade Citigroup Neutral → Buy
Feb-25-20 07:27AM  Raleigh CRO sees double-digit growth in fourth quarter as revenue tops $3B in 2019 American City Business Journals
Feb-24-20 04:14PM  Edited Transcript of PRAH earnings conference call or presentation 21-Feb-20 2:00pm GMT Thomson Reuters StreetEvents -7.38%
02:59PM  Advance Auto Parts, Cree among Triangle companies hit as stocks tumble with rising concern over coronavirus American City Business Journals
09:27AM  PRA Health (PRAH) Q4 Earnings and Revenues Beat Estimates Zacks
05:36AM  PRA Health Sciences, Inc. Just Released Its Annual Results And Analysts Are Updating Their Estimates Simply Wall St.
Feb-20-20 05:45PM  PRA Health Sciences (PRAH) Q4 Earnings and Revenues Top Estimates Zacks
04:01PM  PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2019 Results and Provides First Quarter and Full Year 2020 Guidance GlobeNewswire
Feb-13-20 12:31PM  PRA Health Sciences (PRAH) Earnings Expected to Grow: Should You Buy? Zacks
Feb-07-20 09:00AM  These Medical Stocks Are Outperforming 95% Of All Stocks Here's Why Investor's Business Daily
Feb-05-20 12:34PM  A Look At The Intrinsic Value Of PRA Health Sciences, Inc. (NASDAQ:PRAH) Simply Wall St.
Feb-03-20 04:01PM  PRA Health Sciences to Report Fourth Quarter 2019 Earnings GlobeNewswire
Jan-22-20 05:16PM  Steven Cohen's Point72 Piles Into Menlo Therapeutics GuruFocus.com
Jan-08-20 01:53PM  Is Now An Opportune Moment To Examine PRA Health Sciences, Inc. (NASDAQ:PRAH)? Simply Wall St.
07:37AM  Collaboration links Iqvia, PPD with Duke, UNC and others American City Business Journals
Jan-07-20 08:45AM  Perspecta and PRA Health Sciences complete successful modernization of Million Veteran Program for U.S. Department of Veterans Affairs PR Newswire
Dec-26-19 10:15AM  How Did PRA Health Sciences Inc (PRAH) Compare Against Top Hedge Fund Stocks in 2019? Insider Monkey
Dec-11-19 11:04AM  PRA Health Sciences's (NASDAQ:PRAH) Wonderful 346% Share Price Increase Shows How Capitalism Can Build Wealth Simply Wall St.
Dec-02-19 09:09PM  Were Hedge Funds Right About Buying PRA Health Sciences Inc (PRAH)? Insider Monkey
Nov-21-19 02:31PM  Edited Transcript of PRAH earnings conference call or presentation 31-Oct-19 1:00pm GMT Thomson Reuters StreetEvents
07:45AM  Triangle company to spearhead new age of drug development American City Business Journals
Nov-20-19 09:08AM  Here's Why You Should Retain PRA Health (PRAH) Stock Now Zacks
Nov-05-19 10:35AM  Is PRA Health Sciences, Inc.'s (NASDAQ:PRAH) P/E Ratio Really That Good? Simply Wall St.
Nov-01-19 07:58AM  PRA Health (PRAH) Q3 Earnings and Revenues Beat Estimates Zacks
Oct-30-19 07:25PM  PRA Health Sciences (PRAH) Beats Q3 Earnings and Revenue Estimates Zacks
04:02PM  PRA Health Sciences, Inc. Reports Third Quarter 2019 Results and Updates Full Year 2019 Guidance GlobeNewswire
Oct-27-19 11:02AM  PRA Health Sciences Inc (PRAH): Hedge Funds In Wait-and-See Mode Insider Monkey
Oct-23-19 10:34AM  PRA Health Sciences (PRAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-17-19 09:43AM  Here's Why You Should Add PRA Health to Your Portfolio Now Zacks
Oct-09-19 04:05PM  PRA Health Sciences to Report Third Quarter 2019 Earnings GlobeNewswire
Oct-08-19 01:48PM  Is PRA Health Sciences, Inc. (NASDAQ:PRAH) Excessively Paying Its CEO? Simply Wall St.
Sep-19-19 10:25AM  PRA Health Simplifies Treatment Decisions With Metys Launch Zacks
Sep-18-19 08:00AM  PRA Health Sciences, Symphony Health Launch Metys(TM) National Market Measurement Tool GlobeNewswire
Sep-09-19 03:14PM  Should You Be Adding PRA Health Sciences (NASDAQ:PRAH) To Your Watchlist Today? Simply Wall St.
10:36AM  Edited Transcript of PRAH earnings conference call or presentation 1-Aug-19 1:00pm GMT Thomson Reuters StreetEvents
Sep-04-19 08:48AM  Raleigh company's largest investor to sell all of its shares $600M-plus American City Business Journals
06:00AM  PRA Health Sciences, Inc. Announces Pricing of Secondary Offering and Concurrent Share Repurchase GlobeNewswire
Sep-03-19 05:59PM  PRA Health Sciences, Inc. Announces $500 Million Share Repurchase Program GlobeNewswire
05:24PM  PRA Health Sciences, Inc. Announces Secondary Offering and Concurrent Share Repurchase GlobeNewswire
Aug-19-19 12:00PM  PRA Health Sciences (NASDAQ:PRAH) Has A Pretty Healthy Balance Sheet Simply Wall St.
10:18AM  PRA Health Sciences Announces Strategic Alliance between Symphony Health and Close-Up International GlobeNewswire
Aug-05-19 02:37PM  Raleigh CRO looks to leverage resources to expand Asian markets American City Business Journals
08:25AM  PRA Health (PRAH) Q2 Earnings Beat, EPS Guidance Narrowed Zacks
Aug-01-19 03:39PM  PRA Health Sciences, Inc. (PRAH) Q2 2019 Earnings Call Transcript Motley Fool -6.42%
Jul-31-19 08:45PM  PRA Health Sciences (PRAH) Beats Q2 Earnings Estimates Zacks
04:05PM  PRA Health Sciences, Inc. Reports Second Quarter 2019 Results and Updates Full Year 2019 Guidance GlobeNewswire
Jul-30-19 11:45AM  Healthcare Stock Q2 Earnings Due on Jul 31: HUM, AMED & More Zacks
Jul-25-19 08:58AM  What PRA Health Sciences, Inc.'s (NASDAQ:PRAH) ROE Can Tell Us Simply Wall St.
Jul-24-19 10:32AM  PRA Health Sciences (PRAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Jul-11-19 10:08AM  CORRECTING and REPLACING -- PRA Health Sciences to Report Second Quarter 2019 Earnings GlobeNewswire
Jul-09-19 04:15PM  PRA Health Sciences to Report Second Quarter 2019 Earnings GlobeNewswire
Jul-02-19 08:42AM  Is PRA Health Sciences's (NASDAQ:PRAH) 142% Share Price Increase Well Justified? Simply Wall St.
Jun-20-19 09:24PM  Heres What Hedge Funds Think About PRA Health Sciences Inc (PRAH) Insider Monkey
Jun-17-19 09:11AM  Here's Why You Should Hold on to PRA Health (PRAH) Stock Now Zacks
May-31-19 09:31AM  PRA Health Sciences (PRAH) Down 5.1% Since Last Earnings Report: Can It Rebound? Zacks
May-14-19 07:00AM  PRA Health Sciences Earns Recognition, Industry Awards GlobeNewswire
May-13-19 06:28PM  Edited Transcript of PRAH earnings conference call or presentation 2-May-19 1:00pm GMT Thomson Reuters StreetEvents
May-09-19 12:00PM  What Should We Expect From PRA Health Sciences, Inc.'s (NASDAQ:PRAH) Earnings Over The Next Year? Simply Wall St.
May-03-19 04:34PM  PRA Health Sciences, Inc.  (PRAH) Q1 2019 Earnings  Call Transcript Motley Fool
06:55AM  PRA Health (PRAH) Q1 Earnings Beat Estimates, Revenues Miss Zacks
May-01-19 06:45PM  PRA Health Sciences (PRAH) Surpasses Q1 Earnings Estimates Zacks
05:39PM  PRA Health Sciences: 1Q Earnings Snapshot Associated Press
04:00PM  PRA Health Sciences, Inc. Reports First Quarter 2019 Results GlobeNewswire
Apr-24-19 12:14PM  Top Ranked Growth Stocks to Buy for April 24th Zacks
10:33AM  PRA Health Sciences (PRAH) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Apr-22-19 11:33AM  Top Ranked Growth Stocks to Buy for April 22nd Zacks
Apr-21-19 09:06PM  Is PRA Health Sciences (PRAH) A Good Stock To Buy? Insider Monkey
Apr-18-19 10:30AM  Top Ranked Growth Stocks to Buy for April 18th Zacks
Apr-16-19 09:25AM  Is PRA Health Sciences, Inc. (NASDAQ:PRAH) Potentially Undervalued? Simply Wall St.
Apr-12-19 11:52AM  Top Ranked Growth Stocks to Buy for April 12th Zacks
Apr-09-19 04:00PM  PRA Health Sciences to Report First Quarter 2019 Earnings GlobeNewswire
07:15AM  3 Under-the-Radar Healthcare Stocks With Great Growth Potential Motley Fool
Apr-08-19 09:00AM  PRA Health Sciences Receives CRO Leadership Awards GlobeNewswire
Apr-04-19 09:35AM  Top Ranked Growth Stocks to Buy for April 4th Zacks
09:30AM  PRAH vs. HQY: Which Stock Is the Better Value Option? Zacks
Apr-02-19 10:27AM  Top Ranked Growth Stocks to Buy for April 2nd Zacks
Apr-01-19 08:45AM  Looking for a Growth Stock? 3 Reasons Why PRA Health Sciences (PRAH) is a Solid Choice Zacks
Mar-26-19 10:29AM  PRA Health Sciences, Inc. (NASDAQ:PRAH): Is It A Good Long Term Opportunity? Simply Wall St.
Mar-20-19 11:05AM  Teladoc to Acquire MedecinDirect, Expand Overseas Business Zacks
Mar-19-19 09:30AM  PRAH vs. HQY: Which Stock Should Value Investors Buy Now? Zacks
Mar-18-19 11:18AM  Encouraging Near-Term Outlook for Medical Services Industry Zacks
Mar-15-19 08:45AM  3 Reasons Growth Investors Will Love PRA Health Sciences (PRAH) Zacks
Mar-07-19 01:58PM  PRA Blue Bell Named 2019 Top Workplace by Philadelphia Inquirer GlobeNewswire
02:35AM  Edited Transcript of PRAH earnings conference call or presentation 28-Feb-19 2:00pm GMT Thomson Reuters StreetEvents
Mar-05-19 07:37AM  PRA Health's (PRAH) Q4 Earnings Top, Revenues Lag Estimates Zacks
Mar-01-19 08:16AM  Why PRA Health Sciences, Inc.s (NASDAQ:PRAH) High P/E Ratio Isnt Necessarily A Bad Thing Simply Wall St.
Feb-28-19 06:54PM  PRA Health Sciences Inc (PRAH) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-27-19 05:21PM  PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2018 Results and Provides First Quarter and Full Year 2019 Guidance GlobeNewswire
Feb-25-19 10:20AM  PRA Health Sciences and CISCRP Collaborate to Provide Clinical Trial Results Summaries to Patients and the Public GlobeNewswire
Feb-20-19 10:31AM  PRA Health Sciences (PRAH) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Feb-12-19 04:11PM  These Medtech Stocks Topped Buy Points Including An IBD 50 Stock Investor's Business Daily
Feb-08-19 08:42AM  Blue-Chip Stocks: Hartford Midcap Fund's Keys To Outperformance Investor's Business Daily
Feb-06-19 07:55AM  Analysis: Positioning to Benefit within Conagra Brands, National Retail Properties, PRA Health Sciences, Westinghouse Air Brake Technologies, YRC Worldwide, and Infinity Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-04-19 04:31PM  PRA Health Sciences to Report Fourth Quarter 2018 Earnings GlobeNewswire
Jan-26-19 12:00PM  3 Top Healthcare Stocks to Buy Right Now Motley Fool
Jan-21-19 07:33AM  PRA Health Sciences, Inc. (NASDAQ:PRAH): Time For A Financial Health Check Simply Wall St.
Jan-16-19 08:30AM  Zosano Appoints Linda Grais M.D., J.D. to Board of Directors GlobeNewswire
Jan-11-19 07:00AM  CROs Poised to Benefit From Biopharma Outsourcing Morningstar
Jan-07-19 09:30AM  TVTY vs. PRAH: Which Stock Is the Better Value Option? Zacks
Jan-03-19 02:48PM  From Iqvia to Red Hat: These execs raked in millions from stock sales in 2018 American City Business Journals -5.58%
Dec-27-18 09:23AM  Stocks down in December for pharma firms in the Triangle American City Business Journals
PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, and bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardio metabolic, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KKR Fund Holdings L.P.10% OwnerSep 06Sale97.416,666,684649,401,68829,300Sep 10 05:09 PM
KKR PRA Investors L.P.10% OwnerSep 06Sale97.416,666,684649,401,68829,300Sep 10 04:51 PM